These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 9004452

  • 1. Biotransformation and detoxification of insecticidal metyrapone analogues by carbonyl reduction in the human liver.
    Rekka EA, Soldan M, Belai I, Netter KJ, Maser E.
    Xenobiotica; 1996 Dec; 26(12):1221-9. PubMed ID: 9004452
    [Abstract] [Full Text] [Related]

  • 2. 11beta-Hydroxysteroid dehydrogenase type 1: tissue-specific expression and reductive metabolism of some anti-insect agent azole analogues of metyrapone.
    Bannenberg G, Martin HJ, Bélai I, Maser E.
    Chem Biol Interact; 2003 Feb 01; 143-144():449-57. PubMed ID: 12604231
    [Abstract] [Full Text] [Related]

  • 3. 11 beta-hydroxysteroid dehydrogenase mediates reductive metabolism of xenobiotic carbonyl compounds.
    Maser E, Bannenberg G.
    Biochem Pharmacol; 1994 May 18; 47(10):1805-12. PubMed ID: 8204097
    [Abstract] [Full Text] [Related]

  • 4. In vitro characterization of the enzymes involved in the metabolism of 1-furan-2-yl-3-pyridin-2-yl-propenone, an anti-inflammatory propenone compound.
    Lee SK, Kim JH, Seo YM, Kim HC, Kang MJ, Jeong HG, Lee ES, Jeong TC.
    Arch Pharm Res; 2008 Jun 18; 31(6):764-70. PubMed ID: 18563359
    [Abstract] [Full Text] [Related]

  • 5. High carbonyl reductase activity in adrenal gland and ovary emphasizes its role in carbonyl compound detoxication.
    Maser E, Hoffmann JG, Friebertshäuser J, Netter KJ.
    Toxicology; 1992 Aug 18; 74(1):45-56. PubMed ID: 1514187
    [Abstract] [Full Text] [Related]

  • 6. Carbonyl reduction of bupropion in human liver.
    Molnari JC, Myers AL.
    Xenobiotica; 2012 Jun 18; 42(6):550-61. PubMed ID: 22339467
    [Abstract] [Full Text] [Related]

  • 7. Reductive metabolism of metyrapone by a quercitrin-sensitive ketone reductase in mouse liver cytosol.
    Maser E, Netter KJ.
    Biochem Pharmacol; 1991 Jun 01; 41(11):1595-9. PubMed ID: 2043149
    [Abstract] [Full Text] [Related]

  • 8. Carbonyl reduction of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by cytosolic enzymes in human liver and lung.
    Maser E, Stinner B, Atalla A.
    Cancer Lett; 2000 Feb 01; 148(2):135-44. PubMed ID: 10695989
    [Abstract] [Full Text] [Related]

  • 9. Oral pharmacokinetics and in-vitro metabolism of metyrapone in male rats.
    Murata H, Higuchi T, Otagiri M.
    J Pharm Pharmacol; 2016 Aug 01; 68(8):970-9. PubMed ID: 27265478
    [Abstract] [Full Text] [Related]

  • 10. Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice.
    Lin DX, Lang NP, Kadlubar FF.
    Drug Metab Dispos; 1995 Apr 01; 23(4):518-24. PubMed ID: 7600922
    [Abstract] [Full Text] [Related]

  • 11. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
    Wang YP, Yan J, Fu PP, Chou MW.
    Toxicol Lett; 2005 Mar 15; 155(3):411-20. PubMed ID: 15649625
    [Abstract] [Full Text] [Related]

  • 12. Role of type-1 11beta-hydroxysteroid dehydrogenase in detoxification processes.
    Maser E, Oppermann UC.
    Eur J Biochem; 1997 Oct 15; 249(2):365-9. PubMed ID: 9370342
    [Abstract] [Full Text] [Related]

  • 13. 17 beta-Estradiol metabolism by hamster hepatic microsomes. Implications for the catechol-O-methyl transferase-mediated detoxication of catechol estrogens.
    Butterworth M, Lau SS, Monks TJ.
    Drug Metab Dispos; 1996 May 15; 24(5):588-94. PubMed ID: 8723741
    [Abstract] [Full Text] [Related]

  • 14. Metyrapone reductase purified partially from liver microsomes of male rats: the enzyme differs from acetohexamide reductase.
    Imamura Y, Murata H, Otagiri M.
    Res Commun Mol Pathol Pharmacol; 1997 May 15; 96(2):219-26. PubMed ID: 9226756
    [Abstract] [Full Text] [Related]

  • 15. 3-ketocholanoic acid is the major in vitro human hepatic microsomal metabolite of lithocholic acid.
    Deo AK, Bandiera SM.
    Drug Metab Dispos; 2009 Sep 15; 37(9):1938-47. PubMed ID: 19487251
    [Abstract] [Full Text] [Related]

  • 16. In vitro biotransformation of finasteride in rat hepatic microsomes. Isolation and characterization of metabolites.
    Ishii Y, Mukoyama H, Ohtawa M.
    Drug Metab Dispos; 1994 Sep 15; 22(1):79-84. PubMed ID: 8149894
    [Abstract] [Full Text] [Related]

  • 17. Metabolism of terfenadine associated with CYP3A(4) activity in human hepatic microsomes.
    Ling KH, Leeson GA, Burmaster SD, Hook RH, Reith MK, Cheng LK.
    Drug Metab Dispos; 1995 Jun 15; 23(6):631-6. PubMed ID: 7587944
    [Abstract] [Full Text] [Related]

  • 18. Reduction of the potential anticancer drug oracin in the rat liver in-vitro.
    Szotáková B, Skálová L, Wsól V, Kvasniècková E.
    J Pharm Pharmacol; 2000 May 15; 52(5):495-500. PubMed ID: 10864136
    [Abstract] [Full Text] [Related]

  • 19. Carbonyl reduction of metyrapone in human liver.
    Maser E, Gebel T, Netter KJ.
    Biochem Pharmacol; 1991 Dec 11; 42 Suppl():S93-8. PubMed ID: 1722672
    [Abstract] [Full Text] [Related]

  • 20. Biotransformation of lovastatin. II. In vitro metabolism by rat and mouse liver microsomes and involvement of cytochrome P-450 in dehydrogenation of lovastatin.
    Vyas KP, Kari PH, Prakash SR, Duggan DE.
    Drug Metab Dispos; 1990 Dec 11; 18(2):218-22. PubMed ID: 1971576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.